. Earth Science News .
EPIDEMICS
S.African girl, 9, is third child with HIV remission: study
By Mari�tte Le Roux
Paris (AFP) July 24, 2017


A South African girl has become only the third child to beat the AIDS virus into long-term remission -- almost nine years and counting -- after receiving a drug cocktail in infancy, researchers announced Monday.

The child was given a ten-month course of anti-AIDS medicine until she was one year old, then taken off the drugs as part of a medical trial.

Eight years and nine months later, the virus is still dormant and the girl healthy without needing treatment, a research team reported at the International AIDS Society conference on HIV science in Paris.

"This new case strengthens our hope that by treating HIV-infected children for a brief period beginning in infancy, we may be able to spare them the burden of life-long therapy," said AIDS expert Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) which funded the study.

Some scientists refer to sustained, drug-free remission as a "functional cure".

Unlike a traditional cure, where the virus is eradicated, the patient still has HIV in their system but it is so weakened that it cannot replicate or spread to sexual partners.

Researchers hope that by treating people as soon as possible after infection, they can one day induce drug-free remission for sustained periods of time, perhaps for good.

This has become a major focus of research amid fading hopes of finding a permanent cure.

The virus has proven more sneaky than imagined -- it has the ability to hide out in human cells and play dead for years, only to re-emerge and attack as soon as treatment is stopped.

Anti-retroviral (ARV) treatment inhibits the virus, but doesn't kill it, and infected people have to take pills daily for life which are costly and have side-effects.

- Relapse possible -

A rare group of infected people -- fewer than one percent -- are able naturally to stop the virus replicating. They are known as "elite controllers", but the mechanism by which they keep the virus at bay remains a mystery.

The girl does not have "elite controller" DNA, said the study authors.

Among people taking virus-suppressing anti-retroviral drugs, only a few have attained drug-free remission.

They include 14 adults in a French trial who were able to quit their medication after three years and stayed healthy.

A French woman aged 20, treated as a baby, has been healthy for 14 years since stopping her medication -- the longest-known remission.

In the United States, the so-called Mississippi Baby was in remission for 27 months after being given ART for the first 18 months of life, but the virus rebounded in a major let-down for researchers.

Now there is the South African girl -- the first case of remission in a child enrolled in a trial to test the effectiveness of early treatment, for a limited time.

"Relapse is a possibility in any case of remission," underlined study co-leader Avy Violari of the University of the Witwatersrand in Johannesburg.

However, "the fact that remission has been for a long period suggests this is likely to be durable," she told AFP.

Researchers do not understand how the girl achieved remission when 410 other children in the trial did not.

"We can't tell if her immune system would have controlled the virus on its own or if the treatment made a difference," said Sharon Lewin, a professor of medicine at the University of Melbourne.

- 'Impressive' -

The girl was diagnosed HIV-positive on her 32nd day of life. After ten months of treatment, levels of HIV in her blood went from "very high" to undetectible.

Tests conducted when she was nine-and-a-half years old showed the vaguest trace of virus, unable to replicate, said the team. The girl had healthy levels of key immune cells.

Some fear the girl is in a minority of people for whom early treatment is sufficient to induce remission.

"Early treatment is good for lots of reasons. Early treatment stops HIV transmission, early treatment means the immune system stays in better shape and early treatment keeps the (virus) reservoirs small," Lewin told AFP.

"Early treatment may also increase the chance of remission, but more studies are needed to really prove this."

Michael Brady, medical director of the Terrence Higgins Trust, an AIDS charity, said remission was "impressive".

"We just need to understand more about why this is and then find ways to apply it to others," he commented on the study.

The children in the trial were monitored for rebounding virus levels, and the experts stressed it is not a good idea for people to take themselves off ARV treatment.

EPIDEMICS
Women with HIV in Cameroon still stigmatised
Yaounde (AFP) July 24, 2017
Blandine, a 28-year-old mother of a baby girl, sits restlessly on a chair in a women's health centre in Cameroon's capital, not knowing how or what to feel as she waits for an HIV test. Blandine is HIV positive. But the waiting is not for her - it is to find out whether her one-year-old girl also has the human immunodeficiency virus. A few minutes later, she has her answer. "I ... read more

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


Comment using your Disqus, Facebook, Google or Twitter login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Smart sensors could save lives

New phase change mechanism could lead to new class of chemical vapor sensors

Robot finds possible melted fuel inside Fukushima reactor

Cheap 3D printed prosthetics could be game changer for Nepal

EPIDEMICS
Writing with the electron beam: Now in silver

Scientists announce the quest for high-index materials

A new synthesis route for alternative catalysts of noble metals

Synthetic materials systems that can "count" and sense their size

EPIDEMICS
Coral gardening is benefiting Caribbean reefs

Vietnam says four fishermen wounded by Indonesian navy

Coastal armoring and its ecological effects in soft sediment environments

Health risk alarm over water rationing in Rome

EPIDEMICS
A new model yields insights into glaciers' retreats and advances

NASA flights gauge summer sea ice melt in the Arctic

Thawing permafrost releases old greenhouse gas

Microbe study highlights Greenland ice sheet toxicity

EPIDEMICS
Disneyland China falls a-fowl of huge turkey leg demand

French grape harvest heading to historic low

Kenyan cattle herders defend 'necessary' land invasions

Using treated graywater for irrigation is better for arid environments

EPIDEMICS
Floodwaters swallow Myanmar pagoda

Eight more dead in India's worsening monsoon floods

25 found dead as toll from Indian floods nears 120: officials

Crustal limestone platforms feed carbon to many of Earth's arc volcanoes

EPIDEMICS
Two German UN peacekeepers killed in Mali helicopter crash

China warns Botswana over Dalai Lama visit

Peace deal eludes Senegal's Casamance, 35 years on

Rwandan forces killing suspects without trial: HRW

EPIDEMICS
How did early humans survive aridity and prolonged drought in Africa

In saliva, clues to a 'ghost' species of ancient human

Artifacts suggest humans arrived in Australia earlier than thought

Startup touts neuro-stimulation as 'medicine for the brain'









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.